Literature DB >> 17255332

Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis.

Pilar Martínez-Martínez1, Mario Losen, Hans Duimel, Peter Frederik, Frank Spaans, Peter Molenaar, Angela Vincent, Marc H De Baets.   

Abstract

The primary autoantigen in myasthenia gravis, the acetylcholine receptor (AChR), is clustered and anchored in the postsynaptic membrane of the neuromuscular junction by rapsyn. Previously, we found that overexpression of rapsyn by cDNA transfection protects AChRs in rat muscles from antibody-mediated loss in passive transfer experimental autoimmune myasthenia gravis (EAMG). Here, we determined whether rapsyn overexpression can reduce or even reverse AChR loss in muscles that are already damaged by chronic EAMG, which mimics the human disease. Active immunization against purified AChR was performed in female Lewis rats. Rapsyn overexpression resulted in an increase in total muscle membrane AChR levels, with some AChR at neuromuscular junctions but much of it in extrasynaptic membrane regions. At the ultrastructural level, most endplates in rapsyn-treated chronic EAMG muscles showed increased damage to the postsynaptic membrane. Although rapsyn overexpression stabilized AChRs in intact or mildly damaged endplates, the rapsyn-induced increase of membrane AChR enhanced autoantibody binding and membrane damage in severe ongoing disease. Thus, these results show the complexity of synaptic stabilization of AChR during the autoantibody attack. They also indicate that the expression of receptor-associated proteins may determine the severity of autoimmune diseases caused by anti-receptor antibodies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255332      PMCID: PMC1851878          DOI: 10.2353/ajpath.2007.060676

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  Assembly and clustering of acetylcholine receptors containing GFP-tagged epsilon or gamma subunits: selective targeting to the neuromuscular junction in vivo.

Authors:  S Gensler; A Sander; A Korngreen; G Traina; G Giese; V Witzemann
Journal:  Eur J Biochem       Date:  2001-04

2.  Acetylcholine receptors direct rapsyn clusters to the neuromuscular synapse in zebrafish.

Authors:  Fumihito Ono; Gail Mandel; Paul Brehm
Journal:  J Neurosci       Date:  2004-06-16       Impact factor: 6.167

3.  Agrin regulates rapsyn interaction with surface acetylcholine receptors, and this underlies cytoskeletal anchoring and clustering.

Authors:  Martijn Moransard; Lucia S Borges; Raffaella Willmann; P Angelo Marangi; Hans Rudolf Brenner; Michael J Ferns; Christian Fuhrer
Journal:  J Biol Chem       Date:  2002-12-16       Impact factor: 5.157

4.  Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations.

Authors:  A G Engel; M Tsujihata; E H Lambert; J M Lindstrom; V A Lennon
Journal:  J Neuropathol Exp Neurol       Date:  1976 Sep-Oct       Impact factor: 3.685

5.  Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome.

Authors:  Kinji Ohno; Andrew G Engel; Xin-Ming Shen; Duygu Selcen; Joan Brengman; C Michel Harper; Akira Tsujino; Margherita Milone
Journal:  Am J Hum Genet       Date:  2002-01-14       Impact factor: 11.025

6.  Immunohistochemical study of utrophin and dystrophin at the motor end-plate in myasthenia gravis.

Authors:  H Ito; T Yoshimura; A Satoh; H Takino; M Tsujihata; S Nagataki
Journal:  Acta Neuropathol       Date:  1996-07       Impact factor: 17.088

Review 7.  The role of antibodies in myasthenia gravis.

Authors:  M De Baets; M H W Stassen
Journal:  J Neurol Sci       Date:  2002-10-15       Impact factor: 3.181

8.  Two-photon microscopy for imaging of the (atherosclerotic) vascular wall: a proof of concept study.

Authors:  Marc van Zandvoort; Wim Engels; Kim Douma; Linda Beckers; Mirjam Oude Egbrink; Mat Daemen; Dick W Slaaf
Journal:  J Vasc Res       Date:  2004-01-16       Impact factor: 1.934

9.  E-box mutations in the RAPSN promoter region in eight cases with congenital myasthenic syndrome.

Authors:  Kinji Ohno; Menachem Sadeh; Ilan Blatt; Joan M Brengman; Andrew G Engel
Journal:  Hum Mol Genet       Date:  2003-04-01       Impact factor: 6.150

10.  Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs.

Authors:  V A Lennon; J M Lindstrom; M E Seybold
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

View more
  10 in total

1.  Glycine receptor antibodies in PERM: a new channelopathy.

Authors:  Pilar Martinez-Martinez; Peter C Molenaar; Mario Losen; Marc H de Baets
Journal:  Brain       Date:  2014-08       Impact factor: 13.501

2.  Low Current-driven Micro-electroporation Allows Efficient In Vivo Delivery of Nonviral DNA into the Adult Mouse Brain.

Authors:  Jochen De Vry; Pilar Martínez-Martínez; Mario Losen; Gerard H Bode; Yasin Temel; Thomas Steckler; Harry W M Steinbusch; Marc De Baets; Jos Prickaerts
Journal:  Mol Ther       Date:  2010-06       Impact factor: 11.454

3.  The effect of plasma from muscle-specific tyrosine kinase myasthenia patients on regenerating endplates.

Authors:  W Pascale ter Beek; Pilar Martínez-Martínez; Mario Losen; Marc H de Baets; Axel R Wintzen; Jan J G M Verschuuren; Erik H Niks; Sjoerd G van Duinen; Angela Vincent; Peter C Molenaar
Journal:  Am J Pathol       Date:  2009-09-10       Impact factor: 4.307

4.  Clinical application of clustered-AChR for the detection of SNMG.

Authors:  Guang Zhao; Xiaoqing Wang; Xiaowen Yu; Xiutian Zhang; Yangtai Guan; Jianming Jiang
Journal:  Sci Rep       Date:  2015-06-11       Impact factor: 4.379

5.  Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors--Recommendations for methods and experimental designs.

Authors:  Mario Losen; Pilar Martinez-Martinez; Peter C Molenaar; Konstantinos Lazaridis; Socrates Tzartos; Talma Brenner; Rui-Sheng Duan; Jie Luo; Jon Lindstrom; Linda Kusner
Journal:  Exp Neurol       Date:  2015-03-18       Impact factor: 5.330

Review 6.  Animal models of myasthenia gravis: utility and limitations.

Authors:  Renato Mantegazza; Chiara Cordiglieri; Alessandra Consonni; Fulvio Baggi
Journal:  Int J Gen Med       Date:  2016-03-04

Review 7.  Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture.

Authors:  Inga Koneczny; Ruth Herbst
Journal:  Cells       Date:  2019-07-02       Impact factor: 6.600

8.  AChRs Degeneration at NMJ in Aging-Associated Sarcopenia-A Systematic Review.

Authors:  Zhengyuan Bao; Can Cui; Simon Kwoon-Ho Chow; Ling Qin; Ronald Man Yeung Wong; Wing-Hoi Cheung
Journal:  Front Aging Neurosci       Date:  2020-12-10       Impact factor: 5.750

9.  Prioritizing genes of potential relevance to diseases affected by sex hormones: an example of myasthenia gravis.

Authors:  Mandeep Kaur; Sebastian Schmeier; Cameron R MacPherson; Oliver Hofmann; Winston A Hide; Stephen Taylor; Nick Willcox; Vladimir B Bajic
Journal:  BMC Genomics       Date:  2008-10-13       Impact factor: 3.969

10.  Crosslinking-induced endocytosis of acetylcholine receptors by quantum dots.

Authors:  Chi Wai Lee; Hailong Zhang; Lin Geng; H Benjamin Peng
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.